AnaptysBio, Inc. Announces Collaboration with VLST Corp. to Generate Novel Antibody Therapeutics
Published: Apr 05, 2010
SAN DIEGO--(BUSINESS WIRE)--AnaptysBio, Inc., a privately-held therapeutic antibody platform and product company, today announced a collaboration with VLST Corporation to generate novel multi-antigen specific antibody therapeutics for the treatment of autoimmune and inflammatory disorders. This is the fourth collaboration announced by AnaptysBio during 2010.